Search details
1.
Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.
Blood
; 128(4): 574-83, 2016 07 28.
Article
in English
| MEDLINE | ID: mdl-27235137
2.
Phase I Study of GS-3583, a FLT3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 2024 Jan 31.
Article
in English
| MEDLINE | ID: mdl-38295150
3.
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells.
JHEP Rep
; 5(4): 100664, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36908748
4.
SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma.
Mol Oncol
; 17(2): 284-297, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36400430
5.
EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation.
Clin Cancer Res
; 14(8): 2465-75, 2008 Apr 15.
Article
in English
| MEDLINE | ID: mdl-18413839
6.
Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton.
Development
; 135(22): 3765-74, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-18927155
Results
1 -
6
de 6
1
Next >
>>